Prostate Cancer Canada is encouraging men to get tested for the potentially deadly disease with a bold campaign that references historical and fictional characters in the form of latex gloves – yes, those donned by doctors for the often dreaded digital rectal exam meant to detect the presence of tumours in the male sex gland. Read the article here.
January 2018 Awareness Night Transperineal Prostate Biopsies: a new paradigm in the diagnosis and monitoring of Prostate Cancer Dr. Stanley Flax MB, BCh, FRCSC Staff Urologist, North York General Hospital, Co-Chair, North York General Hospital’s OR Product Standardization & Evaluation Committee, Director, Gale & Graham Wright Prostate Cancer Centre. Dr. Adam Tunis MD, MSc, FRCPC Clinical Director of Medical Imaging Informatics, Staff Radiologist, North York General Hospital Dept. of Medical Imaging CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 36:22 minutes
A team of researchers from Cleveland Clinic, Louis Stokes Cleveland VA Medical Center, Kaiser Permanente Northwest, and other clinical sites have demonstrated that a new blood test known as IsoPSA detects prostate cancer more precisely than current tests in two crucial measures – distinguishing cancer from benign conditions, and identifying patients with high-risk disease. Read the article here.
January 2017 Awareness Night The Future of PSA Based Prostate Cancer (PCa) Screening – Screening Smarter and Individualized Risk Assessment Dr. Raj Satkunasivam, MD, MS, FRCSC Urologic Oncologist, Odette Cancer Centre, Sunnybrook Health Sciences Centre Assistant Professor, Division of Urology, Department of Surgery, University of Toronto CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 40:51 minutes
A pilot study at the Sunnybrook Health Sciences Centre determined the feasibility of using multiparametric prostate magnetic resonance imaging as the primary screening test for prostate cancer. Initial results showed that prostate magnetic resonance imaging was better to predict prostate cancer than prostate specific antigen in an unselected sample of the general population. Read the article here.
Every four minutes, prostate cancer kills someone, somewhere around the world. Researchers at Cambridge Oncometrix, are developing a simple test that will detect the disease early. Dmitry Soloviev is one the scientists who’s helping to develop a test that can indicate the presence of cancer cells. Dr. Dmitry is the principal scientist at Oncometrix. Watch his video and learn more about this innovative test and how scientists are working to develop it further. Read the article.